The EU’s Pharmaceutical Strategy is a roadmap which will accompany policy developments for the years to come. It is important as it offers a rare and concise overview of actions and priorities which guide EU policy action. It is indeed a reference point as much as a...
European Cross-Border Initiatives:Towards Fair Medicine Deals? 18 January 2022 14:00 - 15:15 CET Online This timely event will explore the challenges and opportunities for cross- border collaborations and focus on concrete recommendations to improve access to...
On 16 September 2021, Dr Milka Sokolović, Director General of EPHA gave a speech at the 71st session of the WHO Regional Committee for Europe where she emphasized the need for better access to effective, novel, high-priced medicines and how the Oslo Medicines...
The COVID-19 pandemic has highlighted the importance of addressing shortages of critical medicines and coordinating clinical trials for the development of new medicines. It has also shown how a lack of transparency on clinical trials threatens to delay the development...
Ahead of the publication of the European Commission’s proposal for an operational Health Emergency Preparedness and Response Authority (HERA), to ensure better EU preparedness and response to serious cross border health threats, the European Public Health...